Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer.
Sutera P, Song Y, Van der Eecken K, Shetty AC, English K, Hodges T, Chang J, Fonteyne V, Rana Z, Ren L, Mendes AA, Lumen N, Delrue L, Verbeke S, De Man K, Song DY, Pienta K, Feng FY, Joniau S, Lotan T, Lane B, Kiess A, Rowe S, Pomper M, DeWeese T, Deek M, Sweeney C, Ost P, Tran PT. Sutera P, et al. Among authors: sweeney c. Eur Urol. 2023 Dec;84(6):531-535. doi: 10.1016/j.eururo.2023.04.025. Epub 2023 May 10. Eur Urol. 2023. PMID: 37173210 Free article.
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.
Parry MA, Grist E, Mendes L, Dutey-Magni P, Sachdeva A, Brawley C, Murphy L, Proudfoot J, Lall S, Liu Y, Friedrich S, Ismail M, Hoyle A, Ali A, Haran A, Wingate A, Zakka L, Wetterskog D, Amos CL, Atako NB, Wang V, Rush HL, Jones RJ, Leung H, Cross WR, Gillessen S, Parker CC, Chowdhury S; STAMPEDE collaborators; Lotan T, Marafioti T, Urbanucci A, Schaeffer EM, Spratt DE, Waugh D, Powles T, Berney DM, Sydes MR, Parmar MKB, Hamid AA, Feng FY, Sweeney CJ, Davicioni E, Clarke NW, James ND, Brown LC, Attard G. Parry MA, et al. Among authors: sweeney cj. Res Sq [Preprint]. 2023 Feb 8:rs.3.rs-2488586. doi: 10.21203/rs.3.rs-2488586/v1. Res Sq. 2023. PMID: 36798177 Free PMC article. Preprint.
Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer.
Sutera P, Shetty AC, Song Y, Hodges T, Hoang T, Rana Z, Pienta K, Feng F, Song DY, DeWeese T, Gillessen S, Sweeney C, James N, Attard G, Deek M, Tran PT. Sutera P, et al. Among authors: sweeney c. Eur Urol Oncol. 2024 Apr;7(2):241-247. doi: 10.1016/j.euo.2023.07.014. Epub 2023 Aug 8. Eur Urol Oncol. 2024. PMID: 37558543 Free article.
Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED).
Sentana-Lledo D, Chu X, Jarrard DF, Carducci MA, DiPaola RS, Wagner LI, Cella D, Sweeney CJ, Morgans AK. Sentana-Lledo D, et al. Among authors: sweeney cj. Eur Urol Oncol. 2024 Apr 29:S2588-9311(24)00102-0. doi: 10.1016/j.euo.2024.04.010. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38688766
Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma.
Fankhauser CD, Jandari A, Collette L, Tandstad T, Jiang DM, De Giorgi U, Sweeney C, Terbuch A, Chovanec M, Huddart R, Bokemeyer C, Beyer J, Gillessen S. Fankhauser CD, et al. Among authors: sweeney c. Eur Urol Open Sci. 2023 Sep 9;56:25-28. doi: 10.1016/j.euros.2023.08.008. eCollection 2023 Oct. Eur Urol Open Sci. 2023. PMID: 37711670 Free PMC article.
Precision medicine for prostate cancer: An international perspective.
Hamid AA, Sweeney CJ, Hovens C, Corcoran N, Azad AA. Hamid AA, et al. Among authors: sweeney cj. Urol Oncol. 2024 Apr 12:S1078-1439(24)00334-X. doi: 10.1016/j.urolonc.2024.02.004. Online ahead of print. Urol Oncol. 2024. PMID: 38614920 Review.
Top advances of the year: Genitourinary cancer.
Jackson-Spence F, Young M, Sweeney C, Powles T. Jackson-Spence F, et al. Among authors: sweeney c. Cancer. 2023 Sep 1;129(17):2603-2609. doi: 10.1002/cncr.34907. Epub 2023 Jun 28. Cancer. 2023. PMID: 37378532
1,142 results